370 related articles for article (PubMed ID: 27373313)
1. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
John A; Sivashanmugam M; Umashankar V; Natarajan SK
J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
[TBL] [Abstract][Full Text] [Related]
2. Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII.
Cau Y; Vullo D; Mori M; Dreassi E; Supuran CT; Botta M
Molecules; 2017 Dec; 23(1):. PubMed ID: 29271882
[TBL] [Abstract][Full Text] [Related]
3. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
Biswas S; McKenna R; Supuran CT
Bioorg Med Chem Lett; 2013 Oct; 23(20):5646-9. PubMed ID: 23993330
[TBL] [Abstract][Full Text] [Related]
4. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin 6(7H)yl)urea.
Kumari S; Idrees D; Mishra CB; Prakash A; Wahiduzzaman ; Ahmad F; Hassan MI; Tiwari M
J Mol Graph Model; 2016 Mar; 64():101-109. PubMed ID: 26826799
[TBL] [Abstract][Full Text] [Related]
6. Computational modeling of novel inhibitory peptides targeting proteoglycan like region of carbonic anhydrase IX and
John A; Sivashanmugam M; Natarajan SK; Umashankar V
J Biomol Struct Dyn; 2020 Apr; 38(7):1995-2006. PubMed ID: 31146646
[TBL] [Abstract][Full Text] [Related]
7. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis.
Salmas RE; Senturk M; Yurtsever M; Durdagi S
J Enzyme Inhib Med Chem; 2016; 31(3):425-33. PubMed ID: 25950196
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Molecular Docking Analysis, and Carbonic Anhydrase Inhibitory Evaluations of Benzenesulfonamide Derivatives Containing Thiazolidinone.
Zhang ZP; Yin ZF; Li JY; Wang ZP; Wu QJ; Wang J; Liu Y; Cheng MS
Molecules; 2019 Jun; 24(13):. PubMed ID: 31262068
[TBL] [Abstract][Full Text] [Related]
9. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
[TBL] [Abstract][Full Text] [Related]
10. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
Chahal V; Kakkar R
J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of Nanomolar Inhibition of Tumor-Associated Carbonic Anhydrase IX: X-Ray Crystallographic and Inhibition Study of Lipophilic Inhibitors with Acetazolamide Backbone.
Andring JT; Fouch M; Akocak S; Angeli A; Supuran CT; Ilies MA; McKenna R
J Med Chem; 2020 Nov; 63(21):13064-13075. PubMed ID: 33085484
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors.
Queen A; Khan P; Idrees D; Azam A; Hassan MI
Int J Biol Macromol; 2018 Jan; 106():840-850. PubMed ID: 28830777
[TBL] [Abstract][Full Text] [Related]
13. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA).
Tykvart J; Navrátil V; Kugler M; Šácha P; Schimer J; Hlaváčková A; Tenora L; Zemanová J; Dejmek M; Král V; Potáček M; Majer P; Jahn U; Brynda J; Řezáčová P; Konvalinka J
SLAS Discov; 2020 Oct; 25(9):1026-1037. PubMed ID: 32452709
[TBL] [Abstract][Full Text] [Related]
15. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
16. Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations.
Samanta PN; Das KK
J Mol Graph Model; 2016 Jan; 63():38-48. PubMed ID: 26619075
[TBL] [Abstract][Full Text] [Related]
17. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
[TBL] [Abstract][Full Text] [Related]
19. Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site.
Hou Z; Lin B; Bao Y; Yan HN; Zhang M; Chang XW; Zhang XX; Wang ZJ; Wei GF; Cheng MS; Liu Y; Guo C
Eur J Med Chem; 2017 May; 132():1-10. PubMed ID: 28334643
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
